Use of assisted reproductive technologies and anesthesia in a patient with primary pulmonary hypertension

Fertility and Sterility

Volumn 81, Issue 6, 2004, Pages 1684-1687

  Metzler, Elise ^a   Ginsburg, Elizabeth ^a   Tsen, Lawrence C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

anesthesia; assisted reproductive technologies; Primary pulmonary hypertension

Indexed keywords

ANESTHETIC AGENT; DIGOXIN; FENTANYL; HUMAN MENOPAUSAL GONADOTROPIN; KETAMINE; LEUPRORELIN; MIDAZOLAM; PROPOFOL; PROPRANOLOL; PROSTACYCLIN; RECOMBINANT FOLLITROPIN; RECOMBINANT HORMONE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GENERAL ANESTHESIA; HUMAN; HUMAN CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; NULLIPARA; OOCYTE; OVULATION INDUCTION; PAIN; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEMEN ANALYSIS; TREATMENT PLANNING;

ADULT; ANESTHESIA, GENERAL; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYPERTENSION, PULMONARY; INFUSION PUMPS; OOCYTES; PREGNANCY; SURROGATE MOTHERS; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 2942541462     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.12.021     Document Type: Article

References (19)

1. Rubin L.J. Current concepts primary pulmonary hypertension. N Engl J Med. 336:1997;111-117
2. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44
3. Morse J.H., Horn E.M., Barst R.J. Hormone replacement therapy a possible risk factor in carriers of familiar primary pulmonary hypertension. Chest. 116:1999;847-848
4. Weiss B.M., Zemp L., Seifert B., Hess O.M. Outcome of pulmonary vascular disease in pregnancy a systematic overview from 1978 through 1996. J Am Coll Cardiol. 31:1998;1650-1657
5. Chatterjee K., De Marco T., Alpert J.S. Pulmonary hypertension hemodynamic diagnosis and management. Arch Intern Med. 162:2002;1925-1933
6. Lowson S.M. Inhaled alternatives to nitric oxide. Anesthesiology. 96:2002;1504-1513
7. Smedstad K.G., Cramb R., Morison D.H. Pulmonary hypertension and pregnancy a series of eight cases. Can J Anaesth. 41:1994;502-512
8. Easterling T.R., Ralph D.D., Schmucker B.C. Pulmonary hypertension in pregnancy treatment with pulmonary vasodilators. Obstet Gynecol. 93:1999;494-498
9. British Cardiac Society Guidelines and Medical Practice Committee, approved by the British Thoracic Society and the British Society of Rheumatology. Recommendations on the management of pulmonary hypertension in clinical practice. Heart. 86:(Suppl I):2001;i1-i13
10. Harnett M.J., Bhavani-Shankar K., Datta S., Tsen L.C. In vitro fertilization-induced alterations in coagulation and fibrinolysis as measured by thromboelastography. Anesth Analg. 95:2002;1063-1066
11. Delvigne A., Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 9:2003;77-96
12. Resta T.C., Kanagy N.L., Walker B.R. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol. 280:2001;L88-L97
13. Barberis M.C., Veronese S., Bauer D., De Juli E., Harari S. Immunocytochemical detection of progesterone receptors. A study in a patient with primary pulmonary hypertension. Chest. 107:1995;869-872
14. Rosenfeld C.R., Jackson G.M. Estrogen-induced refractoriness to the pressor effects of infused angiotensin II. Am J Obstet Gynecol. 148:1984;429-435
15. Fuster V., Steele P.M., Edwards W.D., Gersh B.J., McGoon M.D., Frye R.L. Primary pulmonary hypertension natural history and the importance of thrombosis. Circulation. 70:1984;580-587
16. Sakamaki F., Kyotami S., Nagaya N., Sato N., Oya H., Satoh T., et al. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation. 102:2000;2720-2725
17. Barst R.J., Rubin L.H., Long W.A., McGoon M.D., Rich S., Badesch D.B., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 334:1996;296-302
18. Lee T.S., Hou X. Vasoactive effects of ketamine on isolated rabbit pulmonary arteries. Chest. 107:1995;1152-1155
19. Roberts D.H., Lepore J.J., Maroo A., Semigran M.J., Ginns L.C. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest. 120:2001;1547-1555